- Home
- BCAB vs BRN Comparison
BCAB vs BRN Comparison
Compare BCAB & BRN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | BCAB | BRN |
|---|---|---|
| Founded | 2007 | 1956 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medicinal Chemicals and Botanical Products | Oil & Gas Production |
| Sector | Health Care | Energy |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 12.5M | 13.2M |
| IPO Year | 2020 | 1995 |
Fundamental Metrics
Financial Performance| Metric | BCAB | BRN |
|---|---|---|
| Price | $0.18 | $1.07 |
| Analyst Decision | Hold | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $1.00 | N/A |
| AVG Volume (30 Days) | ★ 1.5M | 353.9K |
| Earning Date | 06-15-2026 | 06-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 44.19 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $300,000.00 | ★ $13,697,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.13 | $0.92 |
| 52 Week High | $1.43 | $2.28 |
Technical Indicators
Market Signals| Indicator | BCAB | BRN |
|---|---|---|
| Relative Strength Index (RSI) | 41.77 | 47.80 |
| Support Level | $0.14 | N/A |
| Resistance Level | $0.27 | $1.32 |
| Average True Range (ATR) | 0.02 | 0.15 |
| MACD | 0.01 | -0.01 |
| Stochastic Oscillator | 19.32 | 18.73 |
Price Performance
Historical ComparisonAbout BCAB BioAtla Inc.
BioAtla Inc is a clinical-stage biopharmaceutical company. The company is engaged in the development of a novel class of specific and selective antibody-based therapeutics for the treatment of solid tumor cancer. Its pipeline products comprise mecbotamab vedotin (BA3011), ozuriftamab vedotin (BA3021), and evalstotug (BA3071), and its Phase 1 clinical trial of BA3182 (CAB-EpCAM x CAB-CD3) and Bispecific antibody programs.
About BRN Barnwell Industries Inc.
Barnwell Industries Inc is an oil and gas company engaged in the acquisition, development, production, and sale of crude oil and natural gas. The Company operates through two segments: the Oil and Natural Gas segment, which focuses on oil and natural gas development, production, acquisitions, and sales in the United States and Canada; and the Land Investment segment, which owns leasehold land interests in Hawaii. The Company generates the majority of its revenue from the Oil and Natural Gas segment. The company operates in two geographic regions, the United States and Canada, with Canada contributing the majority of revenue.